Phase III studies and the strategy for integrating chemotherapy into a combined modality approach.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D004341:Drug Evaluation / Q000379:methods*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000628:therapy*
D000970:Antineoplastic Agents